Print Page

BIOPHEN DiXaI (Direct Xa Inhibitors) (CHROMOGENIC)

This Product is CE Marked.
In US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures.

		Quantity in Basket: None SKU: A221030 Manufacturer's Part Number: 221030 Price: $298.00 Quantity:

Product Description BIOPHEN DiXaI kit is a chromogenic assay for in vitro quantitative measurement of Factor Xa Direct Inhibitors. (DiXaIs), such as Rivaroxaban, on human citrated plasma (or purified milieu), using a manual or automated method. This method is not appropriate for indirect inhibitors such as Fondaparinux or heparins, as it is totally insensitive to these inhibitors and is specific for Rivaroxaban. Information SKU ID# Packaging Website Links A221030 (US/CA: A221030-RUO) 3x50 tests www.chromogenicassays.com www.heparinassay.com   Assay Characteristics Kit Components Applications Total Assay Time: < 10 min Detection Threshold: 0.02 µg/mL Dynamic Range: 0 to 0.5 µg/mL Intra-Assay CV: < 5% Inter-Assay CV: < 10-15% R1: 3x2.5 ml of purified Human plasma FXa, lyophilised in presence of stabilizers. R2: 3x2.5 ml of FXa Chromogenic Substrate (CS-11(65)), lyophilised in presence of mannitol. R3: 4x25 ml of Tris-NaCl-EDTA assay reaction buffer at pH 7.85, containing 1% PEG6000 and Sodium azide as preservative. Ready to use. Measurement of Rivaroxaban and other direct Factor Xa inhibitors (DiXaI) in citrated plasma or purified milieu. In US and Canada, this kit is for research use only and should not be used for patient diagnosis or treatment. Streamline Laboratory Procedures Ready-to-use reagents and buffers, from Medicago AB. Available in tablets and pouches.   Downloads Package Inserts MSDS Tech Specs Adaptations BIOPHEN DiXaI - CE BIOPHEN DiXaI - US/CA BIOPHEN DiXaI BIOPHEN DiXaI ACL TOP (Draft) BCS (Draft) STA-R SYSMEX CA7000 (Draft)

Please login to review this product.